SCHEMBL8908377

SCHEMBL8908377

c1ccc(C(CCONCc2ccc3ccccc3c2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC5R P33032 3/20 0.41
MC4R P32245 2/20 0.41
MC3R P41968 1/20 0.39
HRAS P01112 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
IDO1 P14902 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2A6 P11509 1/20 0.38
PPARG P37231 1/20 0.38
FFAR1 O14842 1/20 0.37
ROCK1 Q13464 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR7 P34969 1/20 0.37
HTR2B P41595 1/20 0.37
HTR3A P46098 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14353079 0.75 HRAS (0.64) MC5RMC4RMC3RHRASMAPK1
SCHEMBL17023194 0.75 SLC13A5 (0.53) KMT2ACYP1A2CYP2A6SLC6A4HTR2A
SCHEMBL14353403 0.73 CYP1A2 (0.55) MC5RMC4RMC3RHRASMAPK1
SCHEMBL15059232 0.71 CYP1A2 (0.50) MC5RMC4RKMT2ACYP1A2CYP2A6
SCHEMBL10048276 0.70 CYP1A2 (0.53) MC5RMC4RMC3RMAPK1KMT2A
SCHEMBL8381271 0.69 ASIC3 (0.43) MAPK1PPARG
SCHEMBL6008141 0.66 MC5R (0.71) MC5RMC4RMC3RMAPK1KMT2A
SCHEMBL28508798 0.66 SLC13A5 (0.57) CYP1A2CYP2A6SLC6A4HTR2A
SCHEMBL28168169 0.66 MC5R (0.51) MC5RMC4RMC3RMAPK1KMT2A
SCHEMBL8908374 0.66 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997048676-A1 TRIPHENYLALKYL ANTIMICROBIAL AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1997-12-24 WO disclosed